Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LSTA

Lisata Therapeutics Inc

May 14 • 04:00PM ET

3.08

-0.20 -6.10 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: CUE BLRX SABS TNXP PALI

| Held by: VTI VXF DFSU DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.86	Insider Own	18.83%	Shs Outstand	9.11M	Perf Week	-4.64%
Market Cap	28.05M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.39M	Perf Month	-23.19%
Enterprise Value	14.74M	PEG	-	EPS next Q	-	Inst Own	8.15%	Short Float	0.95%	Perf Quarter	-32.31%
Income	-16.35M	P/S	164.99	EPS this Y	-	Inst Trans	-1.20%	Short Ratio	0.94	Perf Half Y	46.67%
Sales	0.17M	P/B	2.57	EPS next Y	-	ROA	-75.98%	Short Interest	0.07M	Perf YTD	65.59%
Book/sh	1.20	P/C	2.15	EPS next 5Y	-	ROE	-90.13%	52W High	5.07 -39.25%	Perf Year	41.28%
Cash/sh	1.43	P/FCF	-	EPS past 3/5Y	43.29% 24.76%	ROIC	-149.65%	52W Low	1.81 70.17%	Perf 3Y	-6.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	38.24%	Volatility	5.06% 6.92%	Perf 5Y	-85.74%
Dividend TTM	-	EV/Sales	86.70	EPS Y/Y TTM	19.02%	Oper. Margin	-10178.24%	ATR (14)	0.19	Perf 10Y	-96.63%
Dividend Ex-Date	-	Quick Ratio	4.23	Sales Y/Y TTM	-83.00%	Profit Margin	-9618.24%	RSI (14)	33.17	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.23	EPS Q/Q	9.25%	SMA20	-3.93%	Beta	0.82	Target Price	4.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-26.61%	Rel Volume	0.57	Prev Close	3.28
Employees	21	LT Debt/Eq	0.00	Earnings	Nov 06 AMC	SMA200	-0.25%	Avg Volume	74.42K	Price	3.08
IPO	Nov 03, 1995	Option/Short	No / Yes	EPS/Sales Surpr.	8.41% -	Trades		Volume	42,211	Change	-6.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)